xxviiIgnite Institute ....................................................................................... 617
Indiana University Institute for Personalized Medicine ....................... 618
Institute of Medicine’s Role in Personalized Medicine ........................ 619
Jackson Laboratory for Genomic Medicine .......................................... 619
Johns Hopkins Center for Personalized Cancer
Medicine Research ................................................................................ 620
Mayo Clinic’s Centers for Individualized Medicine ............................. 620
Mt. Sinai Medical Center’s Personalized Medicine
Research Program ................................................................................. 621
New York Genome Center .................................................................... 622
P4 Medicine Institute ............................................................................ 622
Personalized Medicine Partnership of Florida ...................................... 623
Partners Personalized Medicine at Massachusetts
General Hospital ................................................................................... 623
Personalized Oncology at Oregon Health & Science University ......... 624
Southeast Nebraska Cancer Center’s Personalized
Medicine Network ................................................................................ 624
Stanford Center for Genomics and Personalized Medicine .................. 625
UAB-HudsonAlpha Center for Genomic Medicine ............................. 626
University of Colorado’s Center for Personalized Medicine ................ 626
UNC Institute for Pharmacogenomics and Individualized
Therapy ................................................................................................. 627
Wisconsin Genomics Initiative ............................................................. 627
Role of Healthcare Organizations ............................................................. 628
Role of the Medical Profession ................................................................. 628
The American Medical Association and Personalized Medicine .......... 629
Medical Education ................................................................................ 629
Off-Label Prescribing and Personalized Medicine ............................... 630
Role of Patients ......................................................................................... 630
Public Attitude Towards Personalized Medicine .................................. 631
Role of Genetic Banking Systems and Databases .................................... 632
Role of Biobanks in Development of Personalized Medicine .............. 632
CARTaGENE for Biobanks in Canada ................................................. 634
Role of Bioinformatics in Development of Personalized Medicine ......... 635
Exploration of Disease-Gene Relationship ........................................... 636
Biosimulation Techniques for Developing Personalized Medicine ...... 636
Health Information Management .......................................................... 637
Electronic Health Records .................................................................... 637
Personalized Prognosis of Disease ........................................................ 642
Global Scope of Personalized Medicine ................................................... 643
Global Alliance for Genomics and Health ............................................ 643
Personalized Medicine in Canada ......................................................... 643
Personalized Medicine in the EU .......................................................... 647
Personalized Medicine in Israel ............................................................ 650
Personalized Medicine in the Developing Countries ............................ 650Contents